KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Abbott Laboratories (ABT) Tax Provisions (2016 - 2025)

Abbott Laboratories' Tax Provisions history spans 17 years, with the latest figure at $582.0 million for Q4 2025.

  • For Q4 2025, Tax Provisions rose 108.08% year-over-year to $582.0 million; the TTM value through Dec 2025 reached $1.9 billion, up 130.4%, while the annual FY2025 figure was $1.9 billion, 130.4% up from the prior year.
  • Tax Provisions for Q4 2025 was $582.0 million at Abbott Laboratories, up from $536.0 million in the prior quarter.
  • Across five years, Tax Provisions topped out at $582.0 million in Q4 2025 and bottomed at -$7.2 billion in Q4 2024.
  • The 5-year median for Tax Provisions is $299.5 million (2024), against an average of -$49.6 million.
  • The largest annual shift saw Tax Provisions skyrocketed 1545.45% in 2021 before it plummeted 3681.59% in 2024.
  • A 5-year view of Tax Provisions shows it stood at $338.0 million in 2021, then fell by 15.09% to $287.0 million in 2022, then fell by 29.97% to $201.0 million in 2023, then tumbled by 3681.59% to -$7.2 billion in 2024, then soared by 108.08% to $582.0 million in 2025.
  • Per Business Quant, the three most recent readings for ABT's Tax Provisions are $582.0 million (Q4 2025), $536.0 million (Q3 2025), and $371.0 million (Q2 2025).